Pacific Biosciences
PACB
PACB
151 hedge funds and large institutions have $375M invested in Pacific Biosciences in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $361M → $375M (+$14.2M)
6.38% less ownership
Funds ownership: 76.89% → 70.5% (-6.4%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
151
Holding in Top 10
1
Calls
$1.18M
Puts
$545K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$3.99M | |
| 3 | +$3.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.28M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.17M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$8.62M | |
| 3 | -$7.65M | |
| 4 |
Goldman Sachs
New York
|
-$5.85M |
| 5 |
KLCMU
Kite Lake Capital Management (UK)
London,
United Kingdom
|
-$5.15M |